- Home
- FENC vs FNLC Comparison
FENC vs FNLC Comparison
Compare FENC & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FENC | FNLC |
|---|---|---|
| Founded | 1996 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.8M | 415.5M |
| IPO Year | 2010 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FENC | FNLC |
|---|---|---|
| Price | $10.75 | $36.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.20 | N/A |
| AVG Volume (30 Days) | ★ 122.5K | 33.4K |
| Earning Date | 11-12-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 2.59 |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $62.55 | N/A |
| Revenue Next Year | $42.10 | N/A |
| P/E Ratio | $164.92 | ★ $14.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $24.63 |
| 52 Week High | $13.25 | $37.61 |
Technical Indicators
Market Signals| Indicator | FENC | FNLC |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 63.41 |
| Support Level | $9.87 | $34.28 |
| Resistance Level | $11.07 | N/A |
| Average True Range (ATR) | 0.67 | 1.09 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 73.17 | 68.86 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.